Review

Drug Resistance to HCV in Direct-Acting Antiviral Treatments
  • Murat Sayan
Viral Hepat J 2023; 29: 90-94 DOI: 10.4274/vhd.galenos.2023.2023-8-4

Research Article

Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data
  • Ayla Doğrugörün
  • Elif Doyuk Kartal
  • Saygın Nayman Alpat
Viral Hepat J 2023; 29: 95-100 DOI: 10.4274/vhd.galenos.2023.2023-6-1
Early Viral Kinetics in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
  • Dilruba Garashova
  • İlker İnanç Balkan
  • Reşat Özaras
  • Mert Ahmet Kuşkucu
  • Ayşenur Özdil
  • Khalis Mustafayev
  • Sibel Yıldız Kaya
  • Rıdvan Karaali
  • Bilgül Mete
  • Gökhan Aygün
  • Neşe Saltoğlu
  • Ömer Fehmi Tabak
Viral Hepat J 2023; 29: 101-107 DOI: 10.4274/vhd.galenos.2023.2023-12-1
Treatment Response to Oral Antivirals in Chronic Hepatitis B Patients: Assessment of Polymorphism in the IL-28B Gene (rs809991)
  • Tuba İlgar
  • Çiğdem Ataman Hatipoğlu
  • Cemal Bulut
  • Şerife Altun Demircan
  • Sami Kınıklı
Viral Hepat J 2023; 29: 108-113 DOI: 10.4274/vhd.galenos.2023.2023-9-3
Comparison of Non-Invasive Methods and Liver Biopsy for Detecting Liver Fibrosis Associated with Chronic Hepatitis B
  • Mine Filiz
  • Cumhur Artuk
  • Merve Dur
  • Uğur Bozlar
  • Yavuz Çekli
  • Rahmet Güner
  • Hanefi Cem Gül
Viral Hepat J 2023; 29: 114-118 DOI: 10.4274/vhd.galenos.2023.2023-10-1
Investigation of the Prevalence of HBsAg, Anti-HCV, and Anti-HIV in a Prison in Turkey: A Point Prevalence Study
  • Esmeray Mutlu Yılmaz
  • Melek Bilgin
  • Zeynep Şentürk Köksal
  • Muhammet Ali Oruç
  • Fehmi Tabak
Viral Hepat J 2023; 29: 119-123 DOI: 10.4274/vhd.galenos.2023.2023-7-1
Health Worker’s Knowledge, Attitude, and Practice Toward Hepatitis B Infection at Benghazi Medical Center
  • Amal Elfaitouri
  • Asma Basheir Elshebani
  • Rima Gebril Omar
Viral Hepat J 2023; 29: 124-131 DOI: 10.4274/vhd.galenos.2023.2023-5-1

Other

2023 Referee Index
Viral Hepat J 2023; 29: 0-0
2023 Author Index
Viral Hepat J 2023; 29: 0-0
2023 Subject Index
Viral Hepat J 2023; 29: 0-0